Determination of the Potency of Extracted, Purified and Formulated Insulin from the Pancreatic Organs of the Sudanese Beef Cattle

Abdella Emam Abdella Baragob, Waleed Hassan AlMalki, Imran Shahid, Ragia Mahmood Hegazy, Khojali Salwa Muhammed, Samia Abdella

Department of Pharmacology and Toxicology, College of Pharmacy, Umm Al Qura University, Makkah, KSA.
Department of Pharmacology and Toxicology, College of Pharmacy, Umm Al Qura University, Makkah, KSA;.
Veterinary Research Institute, Khartoum, Sudan..

DOI: 10.4236/pp.2013.46067                

Abstract

The treatment of type 1 diabetes is mainly dependent on insulin therapy and current formulated insulin formulations are used for its control all over the world. The presented study was designed to evaluate the potency of extracted, purified and formulated insulin from the pancreatic organs of the Sudanese beef cattle. Twenty healthy rabbits were used to conduct the study following subcutaneous administration of the sample insulin, to determine the hypoglycemic effect and to analyze the potency of the testing insulin by the hypoglycemic seizure method, blood sugar method and glucose enzymatic colorimetric test (GOD-PAP) respectively. The potency of the injected insulin samples was estimated by comparing the variation in blood glucose levels produced in the treated animals with that produced by a standard insulin preparation under the suitable conditions of the blood sugar method. The results revealed that the potency of the testing beef insulin samples was slightly higher (i.e., 2.2 USP units/ml, 9%) compared to the standard and assumed potency of the prepared insulin preparations (i.e., 1-2 USP units/ml) which indicated that the solvents and diluents used to prepare the assay dilution might be of higher potency and must be diluted to such an extent that the testing insulin potency must be compatible with the standard dilutions. Furthermore, to determine the choice of an assay to analyze the potency of insulin preparations, not only the accuracy of the result but also the purpose for which the test is to be used and the time limit must be taken into consideration.

Keywords

Blood Sugar Method; Glucose Oxidase Method; Hypoglycemic Effect; Insulin Potency

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	[1] D. A. Vallera, M. G. Bissell and W. Barron, “Accuracy of Portable Blood Glucose Monitoring Effect,” American Journal of Clinical Pathology, Vol. 95, No. 2, 1991, pp. 247-252.
[2]	Z. E. Schar, M. Palmer, J. Amman and C. Berne, “Hypoglycemia Increases the Gastric Emptying Rate in Healthy Subjects,” Diabetic Care, Vol. 18, No. 5, 1995, pp. 674-676.
[3]	A. R. Sacher and A. R. McPherson, “Widmann’s Clinical Interpretation of Laboratory Tests,” 11th Edition, F.A. Davis Company, Philadelphia, 2001.
[4]	Daly, E. Mark, C. Vale, M. Walker, A. Littlefield, K. G. Alberti and J. C. Mathers, “Acute Effects on Insulin Sensitivity and Diurnal Metabolic Profiles of a High-Sucrose Compared with a High Starch Diet,” American Journal of Clinical Nutrition, Vol. 67, No. 6, 1998, pp. 1186-1196.
[5]	H. Eiler, “Endocrine Glands,” In: W. O. Reese, Ed., Dukes’ Physiology of Domestic Animals, 12th Edition, Comstock Press, New York, 2004, pp. 621-669.
[6]	C. Chandler, C. M. Gryniewicz, T. Pringle and F. Cunningham, “Insulin Temperature and Stability under Stimulated Transit Conditions,” American Journal of Health and Pharmacology, Vol. 65, No. 10, 2008, pp. 953-963. doi:10.2146/ajhp070347
[7]	United State Pharmacopoeia, “Insulin Assay: Rabbit Blood Sugar Method,” Vol. 19, United States Pharmacopeial Convention, Rockville, 1975, pp. 611-612.
[8]	United State Pharmacopoeia, “Rabbit Blood Sugar Method Modified with the Glucose Enzymatic Colorimetric Test (GOD-PAP),” United States Pharmacopeial Convention, Rockville, 2002, pp. 435-436.
[9]	P. J. Van Soest, “Nutritional Ecology of the Ruminant,” 2nd Edition, Cornell University Press, Ithaca, 1994.
[10]	United States Pharmacopoeia, “Parenteral, Preparation; Soluble Insulin, Insulin Zinc Suspension Crystalline, Insulin Zinc Suspension Amorphous, Insulin Zinc Suspension Mixed,” United States Pharmacopeial Convention, Rockville, 2000, pp. 807-808.
[11]	M. M. Grajower, C. G. Fraser, J. H. Holcombe, M. L. Daugherty, W. C. Harris and M. R. De Felippis, “How Long Should Insulin Be Used Once a Vial Is Started,” Diabetes Care, Vol. 26, No. 9, 2003, pp. 2665-2669. doi:10.2337/diacare.26.9.2665
[12]	J. B. Henry, “Clinical Diagnosis and Management by Laboratory Methods,” 20th Edition, Saunders Publication, Philadelphia, 2001.
[13]	C. M. Kahn, “Merck Veterinary Manual,” 9th Edition, Merck and Company, Whitehouse Station, 2005.
[14]	J. W. Young, “Gluconeogenesis in Cattle: Significance and Methodology,” Journal of Dairy Science, Vol. 60, No. 1, 1977, pp. 1-15. doi:10.3168/jds.S0022-0302(77)83821-6
[15]	PharmaTutor, “Biological Evaluation of Hypoglycemic Agents,” 2013. http://www.pharmatutor.org/articles/biological-evaluation-of-hypoglycemic-agents?page=0,2